Real World Data on COVID-19 Vaccine Efficacy ‘Extremely Encouraging’
New Dosing Options And Populations Are Being Investigated
Executive Summary
The effectiveness of coronavirus vaccines in preventing infection and symptomatic COVID-19 disease was explored at a virtual meeting held by the European Medicines Agency.
You may also be interested in...
Experts Look At How To Speed Approval Of Variant COVID-19 Vaccines
Senior members of three key regulatory and health bodies this week gave their assessments of the protection that existing COVID-19 vaccines may offer against future strains of the virus, and the requirements for developing and assessing modified vaccines.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.
EU Warns Of Life-Threatening Interactions Between Paxlovid & Some Immunosuppressants
The EU’s pharmacovigilance committee says that a review of the available evidence showed that in several cases, blood levels of immunosuppressants increased rapidly to toxic levels in patients who were taking the Pfizer drug.